Top Stories : Aeterna Zentaris (NASDAQ:AEZS), Synageva BioPharma Corp. (NASDAQ:GEVA), TC PipeLines (NYSE:TCP), Standard Motor Products Inc. (NYSE:SMP), Hospitality Properties (NYSE:HPT)

Aeterna Zentaris Inc. (NASDAQ:AEZS) on Aug. 7 reported financial and operating results as at and for the second quarter ended June 30, 2014. Net loss for the three-month period ended June 30, 2014 was $5.0 million compared to a net income of $9.3 million for the same period in 2013. The decrease in net income is due largely to lower net income from discontinued operations … Continue reading Top Stories : Aeterna Zentaris (NASDAQ:AEZS), Synageva BioPharma Corp. (NASDAQ:GEVA), TC PipeLines (NYSE:TCP), Standard Motor Products Inc. (NYSE:SMP), Hospitality Properties (NYSE:HPT)

Jayne Crisman09/0309/03

Trader’s Watch List: Synageva BioPharma (NASDAQ:GEVA), LRAD (NASDAQ:LRAD), Comerica Incorporated (NYSE:CMA), Tableau Software, Inc. (NYSE:DATA), AAR Corp. (NYSE:AIR)

On Aug. 4, 2014, Synageva BioPharma Corp. (NASDAQ:GEVA) announced that Sanj K. Patel, President and Chief Executive Officer of Synageva will present at the Wedbush Life Sciences Conference in New York City on Tuesday, August 12, 2014, at 8:00 a.m. EDT, and at the Canaccord Genuity Annual Growth Conference in Boston, MA on Wednesday, August 13, 2014, at 8:00 a.m. EDT. Synageva BioPharma Corp. (NASDAQ:GEVA) … Continue reading Trader’s Watch List: Synageva BioPharma (NASDAQ:GEVA), LRAD (NASDAQ:LRAD), Comerica Incorporated (NYSE:CMA), Tableau Software, Inc. (NYSE:DATA), AAR Corp. (NYSE:AIR)

Kristen Barton08/1108/11

Top Losers: ConnectOne Bancorp (NASDAQ:CNOB), Timken (NYSE:TKR), Synageva BioPharma (NASDAQ:GEVA), Fidelity National Financial (NYSE:FNF), MGT Capital Investments (NYSEMKT:MGT)

“Connectone Bancorp, Inc.” (NASDAQ:CNOB)‘s stock had its “outperform” rating reiterated by Keefe, Bruyette & Woods in a research note issued on Tuesday. ConnectOne Bancorp Inc (NASDAQ:CNOB) stock performance was 4.16% in last session and finished the day at $20.03. Traded volume was 355,797.00million shares in the last session and the average volume of the stock remained 14.57K shares. The beta of the stock remained 0.53. … Continue reading Top Losers: ConnectOne Bancorp (NASDAQ:CNOB), Timken (NYSE:TKR), Synageva BioPharma (NASDAQ:GEVA), Fidelity National Financial (NYSE:FNF), MGT Capital Investments (NYSEMKT:MGT)

Kristen Barton07/0207/02

Losers At Healthcare: Synageva BioPharma (NASDAQ:GEVA), Auspex Pharmaceuticals (NASDAQ:ASPX), ImmunoGen (NASDAQ:IMGN), Infinity Pharmaceuticals Inc. (NASDAQ:INFI)

Synageva BioPharma Corp (NASDAQ:GEVA) last released its earnings data on Friday, May 2nd. The company reported ($1.16) earnings per share for the quarter, beating the analysts’ consensus estimate of ($1.19) by $0.03. Analysts expect that Synageva BioPharma Corp will post $-5.90 EPS for the current fiscal year. Synageva BioPharma Corp (NASDAQ:GEVA)stock performance was 5.87% in last session and finished the day at $ 85.40. Traded … Continue reading Losers At Healthcare: Synageva BioPharma (NASDAQ:GEVA), Auspex Pharmaceuticals (NASDAQ:ASPX), ImmunoGen (NASDAQ:IMGN), Infinity Pharmaceuticals Inc. (NASDAQ:INFI)

Mark Doerr05/0505/05

Hot Stocks: FireEye Inc (NASDAQ:FEYE), Synageva BioPharma Corp (NASDAQ:GEVA), Intrexon Corp (NYSE:XON), Puma Biotechnology Inc (NYSE:PBYI)

FireEye, Inc. (NASDAQ: FEYE) filed a registration with the U.S. SEC to sell, from time to time, up to 13,282,316 shares of its Common Stock on behalf of Selling Shareholders. FireEye Inc (NASDAQ:FEYE) stock performance was 5.05% in last session and finished the day at $50.57. Traded volume was 6.04million shares in the last session and the average volume of the stock remained 3.61million shares. … Continue reading Hot Stocks: FireEye Inc (NASDAQ:FEYE), Synageva BioPharma Corp (NASDAQ:GEVA), Intrexon Corp (NYSE:XON), Puma Biotechnology Inc (NYSE:PBYI)

Chris Lewis04/2304/23

NASDAQ most Volatile: InterMune Inc (NASDAQ:ITMN), ACADIA Pharmaceuticals (NASDAQ:ACAD), Clovis Oncology (NASDAQ:CLVS), Synageva BioPharma (NASDAQ:GEVA)

Board of Directors of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) adopted an updated annual incentive cash compensation program for its executive officers to be effective beginning with 2014. The description of this program is set forth in Exhibit 99.1 and is incorporated herein by reference. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) dropped -6.61 percent to $26.01 Friday on volume of 3.37million shares. The intra-day range of the stock was … Continue reading NASDAQ most Volatile: InterMune Inc (NASDAQ:ITMN), ACADIA Pharmaceuticals (NASDAQ:ACAD), Clovis Oncology (NASDAQ:CLVS), Synageva BioPharma (NASDAQ:GEVA)

Mark Doerr03/2403/24